In conclusion, we have identified a specific alternatively spliced NOTCH3 event that differentiate molecular subtypes of DLBCL and display prognostic and predictive biomarker potential in GCB DLBCL. The gene discussed is NOTCH3; the disease is diffuse large B-cell lymphoma.